The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
G Protein-Coupled Receptor Allosterism and Complexing
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dual Signaling Regulated by Calcyon, a D1 Dopamine Receptor Interacting Protein
Lezcano, N., Mrzljak, L., Eubanks, S., Levenson, R., Goldman-Rakic, P., & Bergson, C. (2000) · Science · doi:10.1126/science.287.5458.1660 · Cited by 175
RetractedYung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
On the nature of allosteric transitions: A plausible model
Monod, J., Wyman, J., & Changeux, J.-P. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80285-6 · Cited by 8,825
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,381
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Purinergic Signalling and the Nervous System · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,958
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O., & SCHILD, H. O. (1959) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1959.tb00928.x · Cited by 3,938
The Energy Landscapes and Motions of Proteins
Frauenfelder, H., Sligar, S. G., & Wolynes, P. G. (1991) · Science · doi:10.1126/science.1749933 · Cited by 3,250
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
Allosteric proteins and cellular control systems
Monod, J., Changeux, J.-P., & Jacob, F. (1963) · Journal of Molecular Biology · doi:10.1016/s0022-2836(63)80091-1 · Cited by 2,233
The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves
Hill, A. V., Hill, A. L., & Hill, A. V. (1910) · The Journal of Physiology · Cited by 2,181
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005
De Lean, A., Stadel, J. M., & Lefkowitz, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79672-9 · Cited by 1,612
Molecular tinkering of G protein-coupled receptors: an evolutionary success
Bockaert, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1723 · Cited by 1,550
A study of the ‘desensitization’ produced by acetylcholine at the motor end‐plate
Katz, B., & Thesleff, S. (1957) · The Journal of Physiology · doi:10.1113/jphysiol.1957.sp005838 · Cited by 1,461
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
GABAB-receptor subtypes assemble into functional heteromeric complexes
Kaupmann, K., Malitschek, B., Schuler, V., Heid, J., Froestl, W., Beck, P., Mosbacher, J., Bischoff, S., Kulik, A., Shigemoto, R., et al. (1998) · Nature · doi:10.1038/25360 · Cited by 1,195
Heterodimerization is required for the formation of a functional GABAB receptor
White, J. H., Wise, A., Main, M. J., Green, A., Fraser, N. J., Disney, G. H., Barnes, A. A., Emson, P., Foord, S. M., & Marshall, F. H. (1998) · Nature · doi:10.1038/25354 · Cited by 1,182
Differential signal transduction by five splice variants of the PACAP receptor
Spongier, D., Waeber, C., Pantaloni, C., Holsboer, F., Bockaert, J., Seeburgt, P. H., & Journot, L. (1993) · Nature · doi:10.1038/365170a0 · Cited by 1,182
G-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,166
The Many Faces of G Protein Signaling
Hamm, H. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.669 · Cited by 1,132
GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2
Jones, K. A., Borowsky, B., Tamm, J. A., Craig, D. A., Durkin, M. M., Dai, M., Yao, W.-J., Johnson, M., Gunwaldsen, C., Huang, L.-Y., et al. (1998) · Nature · doi:10.1038/25348 · Cited by 1,079
STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORS
Strader, C. D., Fong, T. M., Tota, M. R., Underwood, D., & Dixon, R. A. F. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000533 · Cited by 1,079
General Conclusions: Teleonomic Mechanisms in Cellular Metabolism, Growth, and Differentiation
Monod, J., & Jacob, F. (1961) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1961.026.01.048 · Cited by 1,072
Conformational Substates in Proteins
Frauenfelder, H., Parak, F., & Young, R. D. (1988) · Annual Review of Biophysics and Biophysical Chemistry · doi:10.1146/annurev.bb.17.060188.002315 · Cited by 993
Pharmacologic Analysis of Drug Receptor Interaction
Kenakin, K. T. (1988) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198803000-00029 · Cited by 927
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000) · Science · doi:10.1126/science.288.5463.154 · Cited by 888
Colquhoun, D. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702164 · Cited by 881
Hebert, T. E., Moffett, S., Morello, J.-P., Loisel, T. P., Bichet, D. G., Barret, C., & Bouvier, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16384 · Cited by 775
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 751
Structural Mechanisms for Domain Movements in Proteins
Gerstein, M., Lesk, A. M., & Chothia, C. (1994) · Biochemistry · doi:10.1021/bi00188a001 · Cited by 744
Gasparini, F., Lingenhöhl, K., Stoehr, N., Flor, P. J., Heinrich, M., Vranesic, I., Biollaz, M., Allgeier, H., Heckendorn, R., Urwyler, S., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00082-9 · Cited by 725
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery
Christopoulos, A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd746 · Cited by 664
Self-citationAgonist-receptor efficacy II: agonist trafficking of receptor signals
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89032-x · Cited by 657
Self-citationCuatrecasas, P. (1974) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.43.070174.001125 · Cited by 639
Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M., & Bouvier, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3684 · Cited by 638
Evidence for a Regulated Interaction between Heterotrimeric G Proteins and Caveolin
Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. E., Hansen, S. H., Nishimoto, I., & Lisanti, M. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.26.15693 · Cited by 608
Potent Inhibition of HIV-1 Infectivity in Macrophages and Lymphocytes by a Novel CCR5 Antagonist
Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C., & Proudfoot, A. E. I. (1997) · Science · doi:10.1126/science.276.5310.276 · Cited by 608
The benzodiazepine binding site of GABAA receptors
Sigel, E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01118-8 · Cited by 594
The Regulator of G Protein Signaling Family
De Vries, L., Zheng, B., Fischer, T., Elenko, E., & Farquhar, M. G. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.235 · Cited by 592
Hall, R. A., Premont, R. T., Chow, C.-W., Blitzer, J. T., Pitcher, J. A., Claing, A., Stoffel, R. H., Barak, L. S., Shenolikar, S., Weinman, E. J., et al. (1998) · Nature · doi:10.1038/33458 · Cited by 585
How receptors talk to trimeric G proteins
Bourne, H. R. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80054-3 · Cited by 567
Role of Heteromer Formation in GABA B Receptor Function
Kuner, R., Köhr, G., Grünewald, S., Eisenhardt, G., Bach, A., & Kornau, H.-C. (1999) · Science · doi:10.1126/science.283.5398.74 · Cited by 562
Identification, sequence, and expression of caveolin-2 defines a caveolin gene family.
Scherer, P. E., Okamoto, T., Chun, M., Nishimoto, I., Lodish, H. F., & Lisanti, M. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.131 · Cited by 561
Oligomerization of μ- and δ-Opioid Receptors
George, S. R., Fan, T., Xie, Z., Tse, R., Tam, V., Varghese, G., & O'Dowd, B. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000345200 · Cited by 556
Inhibition of T-tropic HIV Strains by Selective Antagonization of the Chemokine Receptor CXCR4
Schols, D., Struyf, S., Damme, J. V., Esté, J. A., Henson, G., & Clercq, E. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1383 · Cited by 554
Morphine Activates Opioid Receptors without Causing Their Rapid Internalization
Keith, D. E., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Kang, L., Evans, C. J., & von Zastrow, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19021 · Cited by 552
RGS family members: GTPase-activating proteins for heterotrimeric G-protein α-subunits
Watson, N., Linder, M. E., Druey, K. M., Kehrl, J. H., & Blumer, K. J. (1996) · Nature · doi:10.1038/383172a0 · Cited by 546
Costa, T., & Herz, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7321 · Cited by 536
Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers
Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., & Patel, Y. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7862 · Cited by 527
Energetics of Ligand Binding to Proteins
Weber, G. (1975) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60410-6 · Cited by 523
Berg, K. A., Maayani, S., Goldfarb, J., Scaramellini, C., Leff, P., & Clarke, W. P. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.94 · Cited by 510
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
AbdAlla, S., Lother, H., & Quitterer, U. (2000) · Nature · doi:10.1038/35024095 · Cited by 503
l -Amino acid sensing by the extracellular Ca 2+ -sensing receptor
Conigrave, A. D., Quinn, S. J., & Brown, E. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4814 · Cited by 502
Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness
AbdAlla, S., Lother, H., el Massiery, A., & Quitterer, U. (2001) · Nature Medicine · doi:10.1038/nm0901-1003 · Cited by 496
Mammalian RGS Proteins: Barbarians at the Gate
Berman, D. M., & Gilman, A. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1269 · Cited by 491
The two-state model of receptor activation
Leff, P. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)88989-0 · Cited by 488
Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Dimerization of the δ Opioid Receptor:
Cvejic, S., & Devi, L. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.43.26959 · Cited by 484
Interaction at end-plate receptors between different choline derivatives
Castillo, J. D., & Katz, B. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0018 · Cited by 470
Bouaboula, M., Perrachon, S., Milligan, L., Canat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, J., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22330 · Cited by 461
Dopamine D 1 and adenosine A 1 receptors form functionally interacting heteromeric complexes
Ginés, S., Hillion, J., Torvinen, M., Le Crom, S., Casadó, V., Canela, E. I., Rondin, S., Lew, J. Y., Watson, S., Zoli, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150241097 · Cited by 445
Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go
Nishimoto, I., Okamoto, T., Matsuura, Y., Takahashi, S., Okamoto, T., Murayama, Y., & Ogata, E. (1993) · Nature · doi:10.1038/362075a0 · Cited by 432
On the application of “a plausible model” of allosteric proteins to the receptor for acetylcholine
Karlin, A. (1967) · Journal of Theoretical Biology · doi:10.1016/0022-5193(67)90011-2 · Cited by 428
G0 is a major growth cone protein subject to regulation by GAP-43
Strittmatter, S. M., Valenzuela, D., Kennedy, T. E., Neer, E. J., & Fishman, M. C. (1990) · Nature · doi:10.1038/344836a0 · Cited by 420
Ango, F., Prézeau, L., Muller, T., Tu, J. C., Xiao, B., Worley, P. F., Pin, J. P., Bockaert, J., & Fagni, L. (2001) · Nature · doi:10.1038/35082096 · Cited by 410
A study of the action of picrotoxin on the inhibitory neuromuscular junction of the crayfish
Takeuchi, A., & Takeuchi, N. (1969) · The Journal of Physiology · doi:10.1113/jphysiol.1969.sp008972 · Cited by 410
Mack, M., Luckow, B., Nelson, P. J., Cihak, J., Simmons, G., Clapham, P. R., Signoret, N., Marsh, M., Stangassinger, M., Borlat, F., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.8.1215 · Cited by 405
Hall, R. A., Ostedgaard, L. S., Premont, R. T., Blitzer, J. T., Rahman, N., Welsh, M. J., & Lefkowitz, R. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8496 · Cited by 404
Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy
Gomes, I., Jordan, B. A., Gupta, A., Trapaidze, N., Nagy, V., & Devi, L. A. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-j0007.2000 · Cited by 403
Inverse agonist activity of beta-adrenergic antagonists.
Chidiac, P., Hebert, T. E., Valiquette, M., Dennis, M., & Bouvier, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10022-9 · Cited by 372
Scherer, P. E., Tang, Z., Chun, M., Sargiacomo, M., Lodish, H. F., & Lisanti, M. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16395 · Cited by 355
Ehlert, F. J. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13145-3 · Cited by 351
Membrane organization in G‐protein mechanisms
Neubig, R. R. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.12.8088459 · Cited by 347
GABAB receptors – the first 7TM heterodimers
Marshall, F. H., Jones, K. A., Kaupmann, K., & Bettler, B. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01383-8 · Cited by 345
Litschig, S., Gasparini, F., Rueegg, D., Stoehr, N., Flor, P. J., Vranesic, I., Prézeau, L., Pin, J.-P., Thomsen, C., & Kuhn, R. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12169-4 · Cited by 344
Paton, W. D. M., & Rang, H. P. (1965) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1965.0058 · Cited by 341
Jacoby, D. B., Gleich, G. J., & Fryer, A. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116331 · Cited by 339
Lee, B., Sharron, M., Blanpain, C., Doranz, B. J., Vakili, J., Setoh, P., Berg, E., Liu, G., Guy, H. R., Durell, S. R., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9617 · Cited by 338
Evans, B. N., Rosenblatt, M. I., Mnayer, L. O., Oliver, K. R., & Dickerson, I. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005604200 · Cited by 337
Functional Architecture of the Nicotinic Acetylcholine Receptor: From Electric Organ to Brain
Galzi, J. L., Revah, F., Bessis, A., & Changeux, J. P. (1991) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.31.040191.000345 · Cited by 332
Ligand binding and internal equilibiums in proteins
Weber, G. (1972) · Biochemistry · doi:10.1021/bi00755a028 · Cited by 329
Jordan, B. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011384898 · Cited by 328
Modification of the binding properties of muscarinic receptors by gallamine.
Stockton, J. M., Birdsall, N. J., Burgen, A. S., & Hulme, E. C. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14327-7 · Cited by 328
Molecular Code for Cooperativity in Hemoglobin
Ackers, G. K., Doyle, M. L., Myers, D., & Daugherty, M. A. (1992) · Science · doi:10.1126/science.1553532 · Cited by 323
G-protein-coupled receptors function as oligomers in vivo
Overton, M. C., & Blumer, K. J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00386-9 · Cited by 317
Direct activation of GTP‐binding regulatory proteins (G‐proteins) by substance P and compound 48/80
Mousli, M., Bronner, C., Landry, Y., Bockaert, J., & Rouot, B. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80023-c · Cited by 299
Regions in β-Chemokine Receptors CCR5 and CCR2b That Determine HIV-1 Cofactor Specificity
Rucker, J., Samson, M., Doranz, B. J., Libert, F., Berson, J. F., Yi, Y., Smyth, R. J., Collman, R. G., Broder, C. C., Vassart, G., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81364-1 · Cited by 290
The benzodiazepine binding site of GABAA receptors
Sigel, E., & Buhr, A. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90675-1 · Cited by 290
Fluorescent Labeling of Purified β2 Adrenergic Receptor
Gether, U., Lin, S., & Kobilka, B. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28268 · Cited by 278
Receptor-independent Activators of Heterotrimeric G-protein Signaling Pathways
Takesono, A., Cismowski, M. J., Ribas, C., Bernard, M., Chung, P., Hazard, S., Duzic, E., & Lanier, S. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.47.33202 · Cited by 274
Dopamine D2 Receptor Dimers and Receptor-Blocking Peptides
Ng, G. Y. K., O'Dowd, B. F., Lee, S. P., Chung, H. T., Brann, M. R., Seeman, P., & George, S. R. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1489 · Cited by 273
Horstman, D. A., Brandon, S., Wilson, A. L., Guyer, C. A., Cragoe, E. J., & Limbird, L. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45781-x · Cited by 271
Pagano, A., Rüegg, D., Litschig, S., Stoehr, N., Stierlin, C., Heinrich, M., Floersheim, P., Prezèau, L., Carroll, F., Pin, J.-P., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006230200 · Cited by 271
The classification of seven transmembrane receptors in recombinant expression systems.
Kenakin, T. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06948-0 · Cited by 270
Self-citationEfficacy at g-protein-coupled receptors
Kenakin, T. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd722 · Cited by 263
Self-citationLazareno, S., & Birdsall, N. J. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10255-1 · Cited by 263
Fraser, C. M., Wang, C. D., Robinson, D. A., Gocayne, J. D., & Venter, J. C. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09700-7 · Cited by 259
McVey, M., Ramsay, D., Kellett, E., Rees, S., Wilson, S., Pope, A. J., & Milligan, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008902200 · Cited by 257
THE INHIBITORY EFFECT OF GALLAMINE ON MUSCARINIC RECEPTORS
CLARK, A. L., & MITCHELSON, F. (1976) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1976.tb07708.x · Cited by 251
Unwelcomed Guests with Master Keys: How HIV Uses Chemokine Receptors for Cellular Entry
Doms, R. W., & Peiper, S. C. (1997) · Virology · doi:10.1006/viro.1997.8703 · Cited by 251
Robb, S., Cheek, T. R., Hannan, F. L., Hall, L. M., Midgley, J. M., & Evans, P. D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06385.x · Cited by 248
Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers
Zeng, F.-Y., & Wess, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19487 · Cited by 245
Allosteric enhancement of adenosine A1 receptor binding and function by 2-amino-3-benzoylthiophenes.
Bruns, R. F., & Fergus, J. H. (1990) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09591-4 · Cited by 244
Urwyler, S., Mosbacher, J., Lingenhoehl, K., Heid, J., Hofstetter, K., Froestl, W., Bettler, B., & Kaupmann, K. (2001) · PubMed · Cited by 239
Knoflach, F., Mutel, V., Jolidon, S., Kew, J. N. C., Malherbe, P., Vieira, E., Wichmann, J., & Kemp, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231358298 · Cited by 238
Heteromeric association creates a P2Y-like adenosine receptor
Yoshioka, K., Saitoh, O., & Nakata, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121587098 · Cited by 231
Vaught, J. L., Rothman, R. B., & Westfall, T. C. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90558-6 · Cited by 230
Jakubík, J., Bačáková, L., El-Fakahany, E. E., & Tuček, S. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.172 · Cited by 228
Corset, V., Nguyen-Ba-Charvet, K. T., Forcet, C., Moyse, E., Chédotal, A., & Mehlen, P. (2000) · Nature · doi:10.1038/35037600 · Cited by 223
Structural and functional aspects of G protein-coupled receptor oligomerization
Hébert, T. E., & Bouvier, M. (1998) · Biochemistry and Cell Biology · doi:10.1139/bcb-76-1-1 · Cited by 223
A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3
Sabroe, I., Peck, M. J., Van Keulen, B. J., Jorritsma, A., Simmons, G., Clapham, P. R., Williams, T. J., & Pease, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908864199 · Cited by 219
μ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy
Yu, Y., Zhang, L., Yin, X., Sun, H., Uhl, G. R., & Wang, J. B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.28869 · Cited by 219
Mellado, M., Rodríguez-Frade, J. M., Aragay, A., del Real, G., Martín, A. M., Vila-Coro, A. J., Serrano, A., Mayor, F., & Martínez-A., C. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.805 · Cited by 219
Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders
Gasior, M., Carter, R. B., & Witkin, J. M. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01318-8 · Cited by 218
Forces and factors that contribute to the structural stability of membrane proteins
Haltia, T., & Freire, E. (1995) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(94)00161-w · Cited by 217
Monnot, C., Bihoreau, C., Conchon, S., Curnow, K. M., Corvol, P., & Clauser, E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1507 · Cited by 215
D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties
Scarselli, M., Novi, F., Schallmach, E., Lin, R., Baragli, A., Colzi, A., Griffon, N., Corsini, G. U., Sokoloff, P., Levenson, R., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102297200 · Cited by 214
Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1
Doranz, B. J., Lu, Z. H., Rucker, J., Zhang, T. Y., Sharron, M., Cen, Y. H., Wang, Z. X., Guo, H. H., Du, J. G., Accavitti, M. A., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6305-6314.1997 · Cited by 214
The Cubic Ternary Complex Receptor-Occupancy Model III. Resurrecting Efficacy
Weiss, J. M., Morgan, P. H., Lutz, M. W., & Kenakin, T. P. (1996) · Journal of Theoretical Biology · doi:10.1006/jtbi.1996.0139 · Cited by 212
Self-citationβ-Adrenergic receptors: Evidence for negative cooperativity
Limbird, L. E., Meyts, P. D., & Lefkowitz, R. J. (1975) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(75)90815-3 · Cited by 209
Regulator of G Protein Signaling Proteins: Novel Multifunctional Drug Targets
Zhong, H., & Neubig, R. R. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29606-3 · Cited by 208
Tubulin binds specifically to the signal-transducing proteins, Gs alpha and Gi alpha 1.
Wang, N., Yan, K., & Rasenick, M. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40002-1 · Cited by 204
Neurotransmitter-gated ion channels as unconventional allosteric proteins
Galzi, J.-L., & Changeux, J.-P. (1994) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(94)90218-6 · Cited by 197
Gaddum, J. H. (1957) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07217-5 · Cited by 196
Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A
Lin, R., Karpa, K., Kabbani, N., Goldman-Rakic, P., & Levenson, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011538198 · Cited by 195
The Relation between Classical and Cooperative Models for Drug Action
Colquhoun, D. (1973) · Drug Receptors · doi:10.1007/978-1-349-00910-7_11 · Cited by 192
Kroeger, K. M., Hanyaloglu, A. C., Seeber, R. M., Miles, L. E. C., & Eidne, K. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011311200 · Cited by 190
Cloning and characterization of MUPP1, a novel PDZ domain protein
Ullmer, C., Schmuck, K., Figge, A., & Lübbert, H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00141-0 · Cited by 189
Novel allosteric antagonists shed light on mglu5 receptors and CNS disorders
Spooren, W. P. J. M., Gasparini, F., Salt, T. E., & Kuhn, R. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01694-1 · Cited by 189
Neve, K. A., Cox, B. A., Henningsen, R. A., Spanoyannis, A., & Neve, R. L. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11081-x · Cited by 189
The problem of the heme interactions in hemoglobin and the basis of the bohr effect
Wyman, J., & Allen, D. W. (1951) · Journal of Polymer Science · doi:10.1002/pol.1951.120070506 · Cited by 188
Hall, D. A. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12715-0 · Cited by 187
Ciruela, F., Escriche, M., Burgueño, J., Angulo, E., Casadó, V., Soloviev, M. M., Canela, E. I., Mallol, J., Chan, W.-Y., Lluis, C., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006960200 · Cited by 180
Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity
Kenakin, T. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89020-3 · Cited by 176
Self-citationCooperativity Manifest in the Binding Properties of Purified Cardiac Muscarinic Receptors
Wreggett, K. A., & Wells, J. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22488 · Cited by 174
S100β Stimulates Inducible Nitric Oxide Synthase Activity and mRNA Levels in Rat Cortical Astrocytes
Hu, J., Castets, F., Guevara, J. L., & Van Eldik, L. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2543 · Cited by 173
The Schild regression in the process of receptor classification
Kenakin, T. P. (1982) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y82-036 · Cited by 173
Self-citationBécamel, C., Figge, A., Poliak, S., Dumuis, A., Peles, E., Bockaert, J., Lübbert, H., & Ullmer, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008089200 · Cited by 172
BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity.
Carroll, F. Y., Stolle, A., Beart, P. M., Voerste, A., Brabet, I., Mauler, F., Joly, C., Antonicek, H., Bockaert, J., Müller, T., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.965 · Cited by 171
Fraser, N. J., Wise, A., Brown, J., McLatchie, L. M., Main, M. J., & Foord, S. M. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23257-0 · Cited by 169
Ehlert, F. J. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14182-5 · Cited by 168
Expression of Dopamine D3 Receptor Dimers and Tetramers in Brain and in Transfected Cells
Nimchinsky, E. A., Hof, P. R., Janssen, W. G. M., Morrison, J. H., & Schmauss, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29229 · Cited by 168
β1-Adrenergic Receptor Association with PSD-95
Hu, L. A., Tang, Y., Miller, W. E., Cong, M., Lau, A. G., Lefkowitz, R. J., & Hall, R. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005938200 · Cited by 166
Grosse, R. (1997) · Molecular Endocrinology · doi:10.1210/me.11.9.1305 · Cited by 163
Karpa, K. D., Lin, R., Kabbani, N., & Levenson, R. G. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.677 · Cited by 160
Ligand-dependent G Protein Coupling Function of Amyloid Transmembrane Precursor
Okamoto, T., Takeda, S., Murayama, Y., Ogata, E., & Nishimoto, I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4205 · Cited by 158
RAMPs: accessory proteins for seven transmembrane domain receptors
Foord, S. M., & Marshall, F. H. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01347-4 · Cited by 151
WREGGETT, K. A., & Léan, A. D. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15078-5 · Cited by 151
Tang, Y., Hu, L. A., Miller, W. E., Ringstad, N., Hall, R. A., Pitcher, J. A., Camilli, P. V. D., & Lefkowitz, R. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12559 · Cited by 150
Ng, G., George, S. R., Zastawny, R. L., Caron, M., Bouvier, M., Dennis, M., & O’Dowd, B. F. (1993) · Biochemistry · doi:10.1021/bi00094a032 · Cited by 149
Lee, S. P., O’Dowd, B. F., Ng, G., Varghese, G. K., Akil, H., Mansour, A., Nguyen, T., & George, S. R. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12147-5 · Cited by 149
Blanpain, C., Doranz, B. J., Vakili, J., Rucker, J. B., Govaerts, C., Baik, S., Lorthioir, O., Migeotte, I., Libert, F., Baleux, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34719 · Cited by 149
Suramin analogues as subtype-selective G protein inhibitors.
Freissmuth, M., Boehm, S., Beindl, W., Nickel, P., IJzerman, A. P., HOHENEGGER, M., & Nanoff, C. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08769-3 · Cited by 143
Labrosse, B., Brelot, A., Heveker, N., Sol‐Foulon, N., Schols, D., Clercq, E. D., & Alizon, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6381-6388.1998 · Cited by 142
Zitzer, H., Hönck, H., Bächner, D., Richter, D., & Kreienkamp, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.32997 · Cited by 141
PDZ-dependent Activation of Nitric-oxide Synthases by the Serotonin 2B Receptor
Manivet, P., Mouillet‐Richard, S., Callebert, J., Nebigil, C. G., Maroteaux, L., Hosoda, S., Kellermann, O., & Launay, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9324 · Cited by 141
Dimerization and Domain Swapping in G-Protein-Coupled Receptors A Computational Study
Gouldson, P. R., Higgs, C., Smith, R. E., Dean, M. K., Gkoutos, G. V., & Reynolds, C. A. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00153-6 · Cited by 137
Gonadotropin-releasing Hormone Receptor Microaggregation
Cornea, A. M., Janovick, J. A., Maya‐Núñez, G., & Conn, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007850200 · Cited by 136
Matsui, H., Lazareno, S., & Birdsall, N. J. M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08527-x · Cited by 136
Boger, D. L., Henriksen, S. J., & Cravatt, B. F. (1998) · Current Pharmaceutical Design · doi:10.2174/138161280404221010152220 · Cited by 135
Domain swapping in G-protein coupled receptor dimers
Gouldson, P. R., Snell, C. R., Bywater, R. P., Higgs, C. J., & Reynolds, C. A. (1998) · Protein Engineering Design and Selection · doi:10.1093/protein/11.12.1181 · Cited by 133
Differential Opioid Agonist Regulation of the Mouse μ Opioid Receptor
Blake, A. D., Bot, G., Freeman, J., & Reisine, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.782 · Cited by 131
Is there a ‘lock’ for all agonist ‘keys’ in 7TM receptors?
Schwartz, T. W., & ROSENKILDE, M. M. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10017-1 · Cited by 130
Cox, M. A., Jenh, C., Gonsiorek, W., Fine, J. S., Narula, S. K., Zavodny, P. J., & Hipkin, R. W. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)09238-1 · Cited by 129
Thomas, E. A., Carson, M. J., Neal, M. J., & Sutcliffe, J. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.14115 · Cited by 125
Xie, Z., Lee, S. P., O’Dowd, B. F., & George, S. R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00918-7 · Cited by 124
Dopamine D2 receptor dimers in human and rat brain
Zawarynski, P., Tallerico, T., Seeman, P. M., Lee, S. P., O’Dowd, B. F., & George, S. R. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01588-9 · Cited by 123
Picard, L., Simmons, G., Power, C., Meyer, A., Weiss, R. A., & Clapham, P. R. (1997) · Journal of Virology · doi:10.1128/jvi.71.7.5003-5011.1997 · Cited by 123
Allosteric Activation of the Ca2+ Receptor Expressed in Xenopus laevis Oocytes by NPS 467 or NPS 568
Hammerland, L. G., Garrett, J. E., Hung, B. C. P., Levinthal, C., & Nemeth, E. F. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13280-4 · Cited by 123
George, S. R., Lee, S. P., Varghese, G. K., Zeman, P. R., Seeman, P. M., Ng, G., & O’Dowd, B. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30244 · Cited by 122
Inhibition of receptor/G protein coupling by suramin analogues.
Beindl, W., Mitterauer, T., HOHENEGGER, M., IJzerman, A. P., Nanoff, C., & Freissmuth, M. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09262-4 · Cited by 120
Dopamine D2 Receptor Dimer Formation
Armstrong, D., & Strange, P. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006936200 · Cited by 120
Luebke, A. E., Dahl, G., Roos, B. A., & Dickerson, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3455 · Cited by 116
Blanpain, C., Lee, B., Vakili, J., Doranz, B. J., Govaerts, C., Migeotte, I., Sharron, M. P., Dupriez, V., Vassart, G., Doms, R. W., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.18902 · Cited by 114
Motulsky, H. J., & Insel, P. A. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32754-6 · Cited by 112
Use of Constitutive G Protein-Coupled Receptor Activity for Drug Discovery
Chen, G., Way, J. M., Armour, S. L., Watson, C., Queen, K., Jayawickreme, C. K., Chen, W. J., & Kenakin, T. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26450-6 · Cited by 111
Self-citationSeifert, R., Gether, U., Wenzel‐Seifert, K., & Kobilka, B. K. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.2.348 · Cited by 110
Activation of muscarinic acetylcholine receptors via their allosteric binding sites.
Jakubík, J., Bačáková, L., Lisá, V., El‐Fakahany, E. E., & Tucek, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8705 · Cited by 109
ALLOSTERIC INTERACTIONS AT MUSCARINIC CHOLINOCEPTORS
Christopoulos, A., Lanzafame, A. A., & Mitchelson, F. J. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.t01-4-.x · Cited by 109
Self-citationLazareno, S., Popham, A., & Birdsall, N. J. M. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.1.194 · Cited by 109
Allosteric modulation of A2A adenosine receptors by amiloride analogues and sodium ions
Gao, Z., & IJzerman, A. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00360-9 · Cited by 106
Watson, C., Chen, G., Irving, P. E., Way, J. M., Chen, W.-J., & Kenakin, T. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1230 · Cited by 103
Self-citationNunnari, J. M., Repaske, M. G., Brandon, S., Cragoe, E. J., & Limbird, L. E. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45365-3 · Cited by 101
On the Analysis of Pharmacological Experiments in Terms of an Allosteric Receptor Model
Cd, T. (1973) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13687-0 · Cited by 100
Forces and factors that contribute to the structural stability of membrane proteins
Haltia, T., & Freire, E. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(94)00161-6 · Cited by 99
The LD78β isoform of MIP-1α is the most potent CCR5 agonist and HIV-1–inhibiting chemokine
Menten, P., Struyf, S., Schutyser, E., Wuyts, A., Clercq, E. D., Schols, D., Proost, P., & Damme, J. V. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7318 · Cited by 98
Armour, S. L., Foord, S., Kenakin, T., & Chen, W.-J. (1999) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00074-5 · Cited by 96
Self-citationStrittmatter, S. M., Valenzuela, D., Sudo, Y., Linder, M. E., & Fishman, M. C. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54595-6 · Cited by 96
Roychowdhury, S., Wang, N., & Rasenick, M. M. (1993) · Biochemistry · doi:10.1021/bi00069a034 · Cited by 96
Proška, J., & Tucek, S. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10157-0 · Cited by 94
Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
Chidiac, P., Nouet, S., & Bouvier, M. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09338-1 · Cited by 93
Wiens, B. L., Nelson, C. S., & Neve, K. A. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.435 · Cited by 93
AbdAlla, S., Quitterer, U., Grigoriev, S., Maidhof, A., Haasemann, M., Jarnagin, K., & Müller‐Esterl, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1748 · Cited by 92
Cardiac Muscarinic Receptors. Cooperativity as the Basis for Multiple States of Affinity
Chidiac, P., Green, M. A., Pawagi, A. B., & Wells, J. W. (1997) · Biochemistry · doi:10.1021/bi961939t · Cited by 92
Leppik, R. A., Miller, R. C., Eck, M., & Paquet, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10214-9 · Cited by 92
Gnagey, A. L., Seidenberg, M., & Ellis, J. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.6.1245 · Cited by 91
Conformational changes and drug action.
Burgen, A. S. (1981) · PubMed · Cited by 90
Functional rescue of a constitutively desensitized β2AR through receptor dimerization
Hébert, E., LOISEL, P. T., Adam, L., Éthier, N., ONGE, S. S., & Bouvier, M. (1998) · Biochemical Journal · doi:10.1042/bj3300287 · Cited by 88
Cited by
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Self-citationAllosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
Jeffrey Conn, P., Christopoulos, A., & Lindsley, C. W. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2760 · Cited by 1,063
Self-citationCannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor
Laprairie, R. B., Bagher, A. M., Kelly, M. E. M., & Denovan‐Wright, E. M. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13250 · Cited by 1,039
Small molecule modulation of Smoothened activity
Chen, J. K., Taipale, J., Young, K. E., Maiti, T., & Beachy, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182542899 · Cited by 992
Allosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Self-citation
Metadata
- Authors
- Christopoulos, A., & Kenakin, T.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 54
- Issue
- 2
- Pages
- 323-374
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2095775529
- Cited by
- 931
- References
- 256
- FWCI
- 15.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.